| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44018126 | HTLV-1 | ENSG00000171791.14 | protein_coding | BCL2 | Yes | No | 596 | P10415 |
| TVIS44014467 | HTLV-1 | ENSG00000171791.14 | protein_coding | BCL2 | Yes | No | 596 | P10415 |
| TVIS44014468 | HTLV-1 | ENSG00000171791.14 | protein_coding | BCL2 | Yes | No | 596 | P10415 |
| TVIS44036476 | HTLV-1 | ENSG00000171791.14 | protein_coding | BCL2 | Yes | No | 596 | P10415 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BCL2 |
|---|---|
| DrugBank ID | DB05103 |
| Drug Name | AN-9 |
| Target ID | BE0000246 |
| UniProt ID | P10415 |
| Regulation Type | downregulator |
| PubMed IDs | 11380606 |
| Citations | Rabizadeh E, Bairey O, Aviram A, Ben-Dror I, Shaklai M, Zimra Y: Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient. Eur J Haematol. 2001 Apr;66(4):263-71. doi: 10.1034/j.1600-0609.2001.066004263.x. |
| Groups | Investigational |
| Direct Classification | Fatty acid esters |
| SMILES | CCCC(=O)OCOC(=O)C(C)(C)C |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL100014 |
